SCENAR Therapy in Chronic Non-specific Neck Pain

Shifting away from a medication-centered approach is a major public health priority, particularly in chronic pain management, where non-pharmacological therapies are recommended despite barriers such as limited evidence and low prescriber awareness. SCENAR (Self-Controlled Energo-Neuro Adaptive Regulation), an electrotherapy device, lacks robust randomized controlled trial data. A prior study showed effects in both active and placebo groups after a single session, supporting further investigation. This study aims to assess whether repeated SCENAR sessions improve disability, mobility, and pain in patients with chronic neck pain.

NCT Number	NCT07742228
Lead Sponsor	Hopital Foch Collaborators: Fondation Apicil
Conditions	Cervicalgia, Neck Pain, Chronic Pain
Enrollment	76 participants
Start Date	2026-03-11
Primary Completion	2028-07-30 (estimated)
Study Completion	2028-07-30 (estimated)
Updated on ClinicalTrials.gov	2026-08-03